Amorepacific is seeing a nearly 2% increase in early trading, driven by expectations of growth in its overseas business and improved long-term performance. Recent upgrades to target prices by securities firms have boosted investor sentiment.
As of 9:12 a.m. on the Korea Exchange, Amorepacific shares were trading at 143,300 won, up 2,800 won (1.99%) from the previous trading day. The stock opened at 143,000 won and reached as high as 147,400 won in early trading.
During its Investor Day on September 11, Amorepacific announced long-term goals for its three main growth pillars: Derma Beauty (Aestura & Illyoon), Cosmeceuticals (IOPE), and Hair Care (Mise en Scène, Laboh, and Ryo), aiming for significant progress by 2027. This has led to a wave of target price increases from securities firms, attracting buying interest.
Yu Jin Investment & Securities raised its target price for Amorepacific to 190,000 won, noting that the company’s derma business, which has proven competitive domestically, is entering a phase of global scaling. Analyst Lee Haeni stated, "All three growth pillars—derma beauty, cosmeceuticals, and hair care—are on a common trajectory of transitioning proven domestic competitiveness to global growth, which is a factor for valuation re-rating."
Han Yoo-jung of Hanwha Investment & Securities also increased the target price from 180,000 won to 200,000 won, highlighting that with reduced dependence on China, growth in regions such as the Americas and Europe, the Middle East, and Africa (EMEA), along with the expansion of NGE brands, is expected to enhance both growth potential and stability.
Song Ji-yeon of Sangsangin Securities positively assessed the rapid execution of indie brands combined with the long-accumulated brand assets and global distribution network, setting a target price of 180,000 won.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.